Literature DB >> 24298452

Nimesulide induced histopathological changes in the vas deferens of mice.

Thotakura Balaji1, Manickam Subramanian, Vaithianathan Gnanasundaram, Sharmila Saran Rajendran, Hannah Sugirthabai Rajila Rajendran.   

Abstract

AIM: Nimesulide, a preferential COX-2 inhibitor has 20 times more selectivity towards COX-2 than that of COX-1. COX-2 selective inhibitors cause frequent nephrotoxicity and hepatotoxicity following their usage. This proposes a physiological role of COX-2 in kidney and liver. Not much attention has been focused on the role of COX-2 with respect to reproduction especially in male reproduction, and the available information is scanty. AIMs and
Objectives: The present study aims to investigate the adverse effects of nimesulide in the vas deferens thereby indirectly assess the role of COX-2 in male reproductive tract.
MATERIAL AND METHODS: Nimesulide was administered orally and the animals were maintained for different time periods prior to sacrifice.
RESULTS: The vas deferens of nimesulide treated mice showed extensive histopathological changes such as vacoulation and exfoliation of cells in the epithelial layer.
CONCLUSION: Nimesulide administration leads to cytotoxic effects suggestive of apoptosis in the vas deferens of mice.

Entities:  

Keywords:  COX-2; Mice; Nimesulide; Vas deferens

Year:  2013        PMID: 24298452      PMCID: PMC3843396          DOI: 10.7860/JCDR/2013/6693.3446

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

1.  Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts.

Authors:  A Kirschenbaum; D R Liotta; S Yao; X H Liu; A P Klausner; P Unger; E Shapiro; I Leav; A C Levine
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  Management of Inflammatory Pain with Selective COX-2 Inhibitors: Promises and Facts.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

3.  The critical role of mitochondrial energetic impairment in the toxicity of nimesulide to hepatocytes.

Authors:  Fábio E Mingatto; Tiago Rodrigues; Acácio A Pigoso; Sérgio A Uyemura; Carlos Curti; Antonio C Santos
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

4.  Intracellular unesterified arachidonic acid signals apoptosis.

Authors:  Y Cao; A T Pearman; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis.

Authors:  M L Hull; A Prentice; D Y Wang; R P Butt; S C Phillips; S K Smith; D S Charnock-Jones
Journal:  Hum Reprod       Date:  2004-11-26       Impact factor: 6.918

6.  Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.

Authors:  F Giuliano; T D Warner
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

7.  Comparative analgesic activity of nimesulide and diclofenac by intramuscular route: correlation with pharmacokinetic profile of nimesulide.

Authors:  S K Gupta; T Velpandian; P Mathur; S Sengupta
Journal:  Pharmacology       Date:  1998-03       Impact factor: 2.547

8.  Constitutive expression of cyclooxygenase-2 in rat vas deferens.

Authors:  J A McKanna; M Z Zhang; J L Wang; H Cheng; R C Harris
Journal:  Am J Physiol       Date:  1998-07

9.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01

10.  Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.

Authors:  M R Panara; R Padovano; M G Sciulli; G Santini; G Renda; M T Rotondo; A Pace; C Patrono; P Patrignani
Journal:  Clin Pharmacol Ther       Date:  1998-06       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.